Delgocitinib ointment is a small molecule (molecular weight 310.35 g/mol) pan‐JAK inhibitor that inhibits all JAK family kinases (JAK1, JAK2, JAK3, and tyrosine kinase 2) and reduces inflammation associated with AD by suppressing the activation of immune cells [4]. This evidence concerns the gene JAK1 and Alzheimer disease.